These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 455721)

  • 1. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
    Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
    Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
    László A; Klujber L
    Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ; Tomas FM; Stern LM
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
    Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
    Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
    Elia M; Carter A; Bacon S; Winearls CG; Smith R
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.
    Afting EG; Bernhardt W; Janzen RW; Röthig HJ
    Biochem J; 1981 Nov; 200(2):449-52. PubMed ID: 7340846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
    Rennie MJ; Millward DJ
    Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
    [No Abstract]   [Full Text] [Related]  

  • 12. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment.
    Kawai H; Adachi K; Nishida Y; Inui T; Kimura C; Saito S
    J Neurol; 1993; 240(3):181-6. PubMed ID: 8482992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of 3-methylhistidine and creatinine by healthy Dutch children during day and night. The influence of age and sex.
    Speek AJ; Thissen JT; Schrijver J
    J Clin Chem Clin Biochem; 1986 Jul; 24(7):465-70. PubMed ID: 3734709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
    Röthig HJ; Bernhardt W; Afting EG
    Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenetic significance of creatine metabolism in progressive muscular dystrophy].
    PERSSON I
    Nord Med; 1952 Nov; 48(46):1589-90. PubMed ID: 13025910
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios.
    Sjölin J; Stjernström H; Henneberg S; Hambraeus L; Friman G
    Am J Clin Nutr; 1989 Jan; 49(1):62-70. PubMed ID: 2912013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary 3-methylhistidine:creatinine ratio in patients on long-term parenteral nutrition.
    Milewski P; Holbrook I; Irving M
    JPEN J Parenter Enteral Nutr; 1980; 4(3):286-9. PubMed ID: 6772809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion.
    Tomas FM; Ballard FJ; Pope LM
    Clin Sci (Lond); 1979 Apr; 56(4):341-6. PubMed ID: 477219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.